Differences in Cascade Genetic Testing Among Families With Hereditary Cancer Risk - Takeaways - MDSpire

Differences in Cascade Genetic Testing Among Families With Hereditary Cancer Risk

  • By

  • Elia Namey

  • Carolyn Horton

  • Beth Dudley

  • Cassidy Carraway

  • Timothy Komala

  • Carrie Milliard

  • Tara Namey

  • Eve Karloski

  • Randall Brand

  • June 30, 2026

  • 0 min

Share

  • 1

    Germline genetic testing informs medical management for individuals with hereditary cancer predisposition through cascade testing of family members.

  • 2

    Cascade testing allows for early intervention in asymptomatic individuals, potentially improving cancer surveillance and survival rates.

  • 3

    Demographic factors such as race, ethnicity, and socioeconomic status influence the adoption rates of genetic testing among probands.

  • 4

    Studies indicate that cascade testing is performed for only a minority of probands, highlighting disparities in cancer prevention opportunities.

  • 5

    The study aims to assess cascade testing rates and factors affecting uptake, including demographic, socioeconomic, and clinical variables.

Original Source(s)

Differences in Cascade Genetic Testing Among Families With Hereditary Cancer Risk

  • by Elia Namey, Carolyn Horton, Beth Dudley, Cassidy Carraway, Timothy Komala, Carrie Milliard, Tara Namey, Eve Karloski, Randall Brand

  • June 30, 2026

Related Content

Distinct trajectories of low anterior resection syndrome following ileostomy reversal

Effectiveness and safety of carbon ion radiotherapy for stage III non-small cell lung cancer: a single-center retrospective study

Breast Cancer Incidence in Asian American, Native Hawaiian, and Pacific Islander Populations